Information
-
Trademark
-
77863052
-
International Classifications
- 5 - Pharmaceutical and veterinary preparations
- 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
- 28 - Games and playthings
-
Filing Date
November 02, 2009
15 years ago
-
Transaction Date
July 09, 2012
12 years ago
-
Status Date
July 09, 2012
12 years ago
-
Published for Opposition Date
April 13, 2010
14 years ago
-
Location Date
February 14, 2012
13 years ago
-
Status Code
606
-
Current Location
DIVISIONAL UNIT
Employee Name
SNAPP, TINA LOUISE
-
Attorney Docket Number
1070-TM-186
Attorney Name
Kenneth F. Florek
Law Office Assigned Location Code
M70
-
Owners
Mark Drawing Code
4000
Mark Identification
SINUPHANT
Case File Statements
- GS0051: Pharmaceutical preparations for use in the treatment, cure, mitigation or prevention of gingivitis, halitosis, stomatitis, periodontitis, inflammation of the oral cavity and pharyngeal cavity, hypersensitivity of teeth, angina, atherosclerosis, bronchial asthma, circulatory disorders, constipation, diarrhoea, heart failure, heart rhythm disorders, high blood pressure, indigestion, insomnia, migraine, motion sickness, nausea, peptic ulcers, vomiting, allergy, gynaecological disorders affecting menstruation, sterility, menstrual syndromes, dysmenorrhoea, infertility, genital tract infections, pelvic inflammatory diseases, vaginal discomfort due to menopausal atrophic changes, anatomical abnormalities of the head, the extremities, chest, abdomen and organs, neoplasia, breast neoplasm, breast cancer, mamma carcinoma, mastopathy, mastodynia, premenstrual syndrome, climateric complaints, breast pain, blood conditions and disorders, blood circulation disorders, high blood pressure, hypertension, pulmonary diseases, heart rhythm disorders, heart failure, urological diseases, sexually transmitted diseases and inflammatory pelvic diseases, menopausal complaints due to therapeutically induced menopause, tamoxifen induced hot flushes of breast cancer survivors, climactic sleep disturbances, depressive moods, protection of the skeletal system, osteoporosis, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, psycho vegetative disorders, depressive syndrome, anxiety, nervous unrest, peripheral nervous system infections, peripheral nervous system movement disorders, nerve compression syndromes, neuritis, neuralgia and regional pain syndromes, diseases and disorders of the kidney, urological disorders, chronic infections of the bladder, cystitis, pyelonephritis, glomerulonephritis, interstitial nephritis, neprholithiasis, cancer, urolith prophylaxis, dizziness, migraine, depression, inflammations of the upper and lower respiratory organs, sinuses, bronchitis, tonsillitis, arthritis, osteoarthritis, fever, cough, cold, Alzheimer's disease, infection of respiratory tract, infection of urinary tract, urinary obstruction, chronic venous insufficiency, prostate hyperplasia, muscle pains, soft tissue rheumatism, musculoskeletal disease, liver disease, hepatitis, cirrhosis of liver, periodontal diseases and dental caries; pharmaceutical preparations for use as an antidepressant, diuretic, hypnotic, sedative, analeptic, and tranquilizer; haemorrhoidal ointment, laxative, nasal decongestant capsules, nasal spray preparations, non-narcotic analgesics, throat lozenges; medicinal preparations in tablet form, namely, menstruation circulation regulating tablets; pharmaceutical preparations, namely, for hormone regulation and hormone replacement; pharmaceutical preparations for sensory organs, namely, for use in ophthalmology, otolaryngology and dermatology; pharmaceutical preparations for regulation and strengthening of the immune system; pharmaceutical preparations for treating of and providing temporary relief for occasional minor irritation, pain, sore mouth, sore gums, sore throat, pain associated with canker sores, pain due to minor irritation or injury of the mouth and gums, pain due to minor dental procedures, pain due to minor irritations caused by dentures or orthodontic appliances, sore gums due to teething in infants and children four months of age and older; pharmaceutical products, namely, medicated dental, gum and mouth washes, medicated dental, gum and mouth rinse, medicated toothpastes, medicated oral-care gels, medicated dental gels, medicated lozenges, cough lozenges, medicated chewing gum, medicated gels and fluids in the nature of dental bleaching gels, gum balms, medicated dental floss, medicated dental tapes, medicated dental ribbons, medicated teeth whitener gels, medicated toothpicks, fluoride chewing gum and chewable tablets for disclosing dental plaque and tartar; pharmaceutical preparations for dental purposes, namely, plaque disclosing reagents, periodontal diagnostic reagents for medical purposes for detecting derivatives from periodontal bacteria, caries, diagnostic reagents for detecting derivatives from caries-causing bacteria and medicines for the prevention and treatment of periodontal diseases, dental caries, canker sores, cold sores, mucositis and oral and tongue cancers; medicated mouth sprays and desensitizers; plant extracts for veterinary and pharmaceutical purposes; sanitary preparations for medical use; sanitary preparations for hygiene, namely, antiseptics, oral antiseptics, disinfectants for hygiene purposes; sanitary preparations for the treatment, cleaning and protection of the skin; dietetic foods adapted for medical use in the form of tablets, drops, capsules, extract preparations, balms or in liquid form; food for medically restricted diets, food for diabetics, food supplements containing plant extracts, food supplements derived from plants or plant extracts, all aforesaid goods in the form of tablets, drops, capsules, extract preparations, balms or in liquid form; vitamin and mineral supplements; food supplements, namely, herbal teas for medicinal purposes and medicinal teas; nutritional additives for medicinal purposes for use in foods and dietary supplements for human consumption; dietetic food supplements; dietary supplements; food supplements and dietary food supplements; mineral food supplements, food supplements based on amino acids, minerals and/or trace elements; dietary supplements; food supplements and dietary food supplements; plant extracts for pharmaceutical purposes; medical plasters; materials for dressings, namely, gauze and bandages; all purpose disinfectants; material for stopping teeth; dental wax
- GS0091: Downloadable electronic publications in the nature of magazines, journals, newsletters, periodicals, catalogues, brochures, manuals, leaflets, package inserts in the field of medicine and phytopharmacy; downloadable electronic publications in the nature of press releases featuring information on medicine and phytopharmacy; pre-recorded magnetic data carriers featuring medicine and phytopharmacy; small weighing, measuring, signalling, checking and supervision apparatus, namely, pocket calculators, scales, balances, measuring rules, thermometers, computer storage devices, namely, flash drives, flash memory cards, memory cards and computer memory hardware to be used as an advertising medium; spectacles, namely, eyeglasses and goggles; protective helmets, namely, bicycle helmets; personal computers; DVD, CD, magnetic-tape recorders and players
- GS0281: Games and playthings, namely, board games, card games, dice games, memory games, party games, action skill games, dolls and puppets; positionable toy figures; gymnastic and sporting articles, namely, treadmills, stair machines, stationary exercise bikes, trampolines, skipping ropes, soccer balls, tennis balls, racket balls; rubber balls for games; hockey pucks, rackets; paddles for use in paddle ball games; decorations for Christmas trees, except lighting apparatus and confectionery
Case File Event Statements
-
7/9/2012 - 12 years ago
42 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Type: MAB6
-
7/9/2012 - 12 years ago
41 - ABANDONMENT - NO USE STATEMENT FILED
Type: ABN6
-
2/16/2012 - 13 years ago
40 - CORRECTED NOA E-MAILED
Type: NOAC
-
2/14/2012 - 13 years ago
39 - DIVISIONAL PROCESSING COMPLETE
Type: DPCC
-
1/24/2012 - 13 years ago
38 - DIVISIONAL REQUEST RECEIVED
Type: DRRR
-
1/24/2012 - 13 years ago
37 - TEAS REQUEST TO DIVIDE RECEIVED
Type: ERTD
-
1/24/2012 - 13 years ago
36 - REQUEST TO DIVIDE UNTIMELY, REFUSED, OR WITHDRAWN
Type: UNTD
-
1/4/2012 - 13 years ago
35 - TEAS REQUEST TO DIVIDE RECEIVED
Type: ERTD
-
12/31/2011 - 13 years ago
34 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
12/30/2011 - 13 years ago
33 - EXTENSION 3 GRANTED
Type: EX3G
-
12/6/2011 - 13 years ago
32 - EXTENSION 3 FILED
Type: EXT3
-
12/30/2011 - 13 years ago
31 - CASE ASSIGNED TO INTENT TO USE PARALEGAL
Type: AITU
-
12/6/2011 - 13 years ago
30 - TEAS EXTENSION RECEIVED
Type: EEXT
-
8/8/2011 - 13 years ago
29 - ASSIGNED TO EXAMINER
Type: DOCK
-
6/9/2011 - 13 years ago
28 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
6/7/2011 - 13 years ago
27 - EXTENSION 2 GRANTED
Type: EX2G
-
6/7/2011 - 13 years ago
26 - EXTENSION 2 FILED
Type: EXT2
-
6/7/2011 - 13 years ago
25 - TEAS EXTENSION RECEIVED
Type: EEXT
-
12/8/2010 - 14 years ago
24 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
12/6/2010 - 14 years ago
23 - EXTENSION 1 GRANTED
Type: EX1G
-
12/6/2010 - 14 years ago
22 - EXTENSION 1 FILED
Type: EXT1
-
12/6/2010 - 14 years ago
21 - TEAS EXTENSION RECEIVED
Type: EEXT
-
6/23/2010 - 14 years ago
20 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
6/8/2010 - 14 years ago
19 - NOA MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM
-
4/13/2010 - 14 years ago
18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
4/13/2010 - 14 years ago
17 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
3/9/2010 - 14 years ago
16 - LAW OFFICE PUBLICATION REVIEW COMPLETED
Type: PREV
-
3/9/2010 - 14 years ago
15 - ASSIGNED TO LIE
Type: ALIE
-
2/17/2010 - 15 years ago
14 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
2/17/2010 - 15 years ago
13 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
2/17/2010 - 15 years ago
12 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
2/17/2010 - 15 years ago
11 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
2/17/2010 - 15 years ago
10 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
2/12/2010 - 15 years ago
9 - NOTIFICATION OF PRIORITY ACTION E-MAILED
Type: GPRN
-
2/12/2010 - 15 years ago
8 - PRIORITY ACTION E-MAILED
Type: GPRA
-
2/12/2010 - 15 years ago
7 - PRIORITY ACTION WRITTEN
Type: CPRA
-
2/8/2010 - 15 years ago
6 - NOTIFICATION OF PRIORITY ACTION E-MAILED
Type: GPRN
-
2/8/2010 - 15 years ago
5 - PRIORITY ACTION E-MAILED
Type: GPRA
-
2/8/2010 - 15 years ago
4 - PRIORITY ACTION WRITTEN
Type: CPRA
-
2/5/2010 - 15 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
11/5/2009 - 15 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Type: NWOS
-
11/5/2009 - 15 years ago
1 - NEW APPLICATION ENTERED IN TRAM
Type: NWAP